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We report a fatal case of encephalitis caused by
Acanthamoeba in a 24-year-old woman from India with sys-
temic lupus erythematosus. Diagnosis was made by identi-
fication of amebas in brain sections by immuno-
fluorescence analysis and confirmed by demonstrating
Acanthamoeba mitochondrial 16S rRNA gene DNA in brain
tissue sections.
A
canthamoeba spp. are free-living amebae that cause
granulomatous amebic encephalitis (GAE), most often
in immunocompromised hosts, including HIV/AIDS and
organ transplant patients and those receiving immunosup-
pressive medication (1). These organisms have also been
associated with amebic keratitis, mainly in contact lens
wearers, as well as with cutaneous, nasopharyngeal, and
disseminated infections and amebic encephalitis. 
Amebic encephalitis results from the hematogenous
spread of the amebae from the initial portals of entry (skin,
respiratory system) to the brain parenchyma. GAE is found
worldwide (1); it develops as a subclinical infection and is
difficult to diagnose because of vague symptoms. It is usu-
ally identified in a biopsy specimen of brain lesions or dur-
ing postmortem examination. 
Opportunistic infections are increasing because of
HIV/AIDS, chemotherapeutic treatments, organ transplant
procedures, and debilitating diseases. Although HIV/AIDS
is under tenuous control in the industrialized world, it is a
burgeoning public health crisis in the developing nations
of Africa, Asia, and the Indian subcontinent. Amebic
encephalitis cases likely are undetected in both industrial-
ized and nonindustrialized nations. Acquainting clinicians
with GAE is important so that they may include amebic
encephalitis in differential diagnoses. We report a fatal
case of Acanthamoeba encephalitis in a patient from India
who was being treated for systemic lupus erythematosus
with corticosteroids and methotrexate. 
The Case
The patient was a 24-year-old woman with a 2-year his-
tory of systemic lupus erythematosus, a history of central
nervous system (CNS) involvement in the recent past, and
autoimmune hemolytic anemia. She was taking chloro-
quine, prednisolone, and methotrexate. Amonth before her
admission to the hospital, low-grade fever, joint pains,
facial rash, and mouth ulcers developed. A day before
admission she had generalized tonic clonic convulsions
that progressed to status epilepticus, followed by loss of
consciousness. On admission, she had a temperature of
40°C, pulse 110/min, blood pressure 126/80 mm Hg, and
neck stiffness. She was stuporous and withdrawing to pain.
Her cerebrospinal fluid (CSF) levels were the following:
protein 174 mg/dL, glucose 42 mg/dL, erythrocytes
1/mm3, and leukocytes 1/mm3. Gram-stained CSF smears
showed no bacteria, and CSF cultures were negative for
bacteria and fungi. She was treated with ceftriaxone,
phenytoin, and pulse steroids. On her second day in the
hospital she was intubated for airway control. By that
evening her pupils became small, quadriparesis developed,
and she became deeply comatose. 
Magnetic resonance imaging (MRI) showed multiple
hypointense necrotic lesions of varying sizes on T2-
weighted imaging. These lesions involved the supra- and
the infratentorial compartments, with the largest lesion in
the left cerebellar hemisphere (Figure 1A). Ascending
transtentorial herniation, significant mass effect, distortion
of the brainstem and fourth ventricle, moderate supratento-
rial ventricular dilatation, and associated sulcal/meningeal
enhancement occurred. Similar lesions of varying intensi-
ty and size were seen in bilateral cerebral hemispheres, left
caudate head, right thalamus, and right half of the pons
(Figure 1B). Three-dimensional multivoxel spectroscopy
through the left basal ganglia and right thalamic lesion
showed elevated lipid areas with increased lactate in the
basal ganglia. Choline levels were normal or minimally
increased.
Emergency posterior fossa craniectomy and foramen
magnum decompression were performed. The left cerebel-
lar lesion had poor demarcation from the adjacent normal
cerebellar tissue and necrotic material in the cavity. The
tissue was soft, discolored with gray-black spots, and
hyperemic. An external ventricular drain was placed, and
dexamethasone treatment was started. However, the
patient’s condition continued to deteriorate and she died
after 5 days. 
Histopathologic analysis of CNS lesions showed foci of
hemorrhagic necrosis. There was a modest chronic inflam-
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cytes, a few plasma cells, and occasionally a few polymor-
phonuclear leukocytes. Amebic trophozoites were
abundant, mainly around blood vessels, but few cysts were
seen (Figure 1C). Amebae were identified by a nucleus
containing a large central nucleolus (Figure 1C, inset).
Formalin-fixed, paraffin-embedded sections were tested
with rabbit antibodies to Acanthamoeba spp., Balamuthia
mandrillaris, and Naegleria fowleri. Amebae were identi-
fied as Acanthamoeba on the basis of their reactivity in
immunofluorescence analysis (Figure 1D).
DNA was extracted for amplification and sequencing
from formalin-fixed brain tissue sections mounted on
slides. Sections were deparaffinized, scraped from slides,
suspended in lysis buffer, and tested by polymerase chain
reaction (PCR) as previously described (2). 
The primer set Aca16Sf1010 (5′-TTATATTGACTTG-
TACAGGTGCT-3′) and Aca16Sr1180 (5′-CATAAT-
GATTTGACTTCTTCTCCT-3′), which was designed to
give an amplimer of 161 bp, was used for detecting
Acanthamoeba DNA (3). Testing for Balamuthia DNA
was also included because this ameba can cause GAE (2).
PCR results were positive for Acanthamoeba DNA(Figure
2, lanes 7–12) but negative for Balamuthia DNA(Figure 2,
lanes 1–6). 
Conclusions
Amebic encephalitis is caused by 3 different amebae:
Acanthamoeba spp, B. mandrillaris, and N. fowleri. Since
Acanthamoeba spp. and B. mandrillaris have similar
forms and cause subacute, prolonged clinical courses, they
have been misidentified in histopathologic examination of
brain tissue (4). N. fowleri causes primary amebic menin-
goencephalitis, a fulminant disease often fatal within 7 to
10 days and usually associated with swimming or other
water-related activities of otherwise immunocompetent
persons, usually children or young adults (1).
Acanthamoeba spp. are ubiquitous in soil and water and
are found in the home environment, including water taps
and sink drains, flowerpot soil, and aquariums. In health-
care settings, they have been isolated from hydrotherapy
baths, dental irrigation equipment, humidifiers, cooling
systems, ventilators, and intensive care units (1,5).
Encephalitis caused by Acanthamoeba is almost always
fatal because of difficulty and delay in diagnosing the dis-
ease and lack of optimal antimicrobial therapy (5). The
portal of entry of the ameba may be a break in the skin or
the respiratory tract by inhalation of wind-blown cysts,
with subsequent spread to the CNS through the circulatory
system (1). In our patient, the portal of entry could not be
determined.
Initial symptoms of GAE are vague and may mimic
neurocysticercosis, tuberculoma, or brain tumor.
Histopathologic analysis is the most common means of
detecting amebae, but their appearance is often unfamiliar
to pathologists, and they may be overlooked or misidenti-
fied (1). Either electron microscopy or immunostaining of
brain tissue is necessary to distinguish Acanthamoeba spp.
from Balamuthia (1). Acanthamoeba in our patient was
identified by immunofluorescence testing using rabbit
antibodies to Acanthamoeba (1,5). PCR was also used to
detect Acanthamoeba DNA in brain tissue. 
In almost all cases, persons with Acanthamoeba infec-
tions are immunocompromised (1). Acanthamoeba infec-
tions in persons with lupus erythematosus who were being
treated with corticosteroids have been reported (6–9).
Corticosteroids, besides reducing inflammation, impair the
immune response, facilitating infection and disease caused
by Acanthamoeba (10). In fixed brain tissue, Acanthamoeba
and B. mandrillaris are similar and both form cysts in tis-
sues (4,5). PCR has been used to identify ameba DNA in
brain tissue and CSF of persons suspected of having bala-
muthiasis (2) and in brain tissue of a patient with primary
amebic meningoencephalitis caused by N. fowleri (11).
In conclusion, Acanthamoeba infection was demon-
strated by hematoxylin and eosin and immunostaining of
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Figure 1. A) Magnetic resonance imaging (MRI) of the patient’s brain showing a large lesion in the left cerebellar hemisphere. B) MRI in
a different plane taken at the same time. Lesions are evident in the right thalamus and the right half of the pons. C) Blood vessel in brain
parenchyma with large numbers of Acanthamoeba in the perivascular space (hematoxylin and eosin stained, magnification ×100). Inset,
higher magnification (×1,000) showing nuclear morphology of the ameba. The dark-stained ameba nucleus with a central nucleolus is
distinctive. D) Immunofluorescent staining of perivascular brain tissue showing many amebae (magnification ×100). brain tissue and PCR detection of ameba mitochondrial
DNA in brain tissue. Treatment with corticosteroids and
methotrexate likely facilitated development of amebic
infection by compromising the patient’s immune system. 
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Figure 2. Results of polymerase chain reaction showing 230-bp
and 161-bp bands for Balamuthia (lanes 1–6) and Acanthamoeba
(lanes 7–12) mitochondrial 16S rRNA gene DNA. Lane 1, molecu-
lar mass marker; lane 2, absence of Balamuthia DNA in patient
brain tissue (5-µL sample); lane 3, positive control (Balamuthia
DNA); lane 4, negative control (Acanthamoeba DNA); lane 5, neg-
ative control (water); lane 6, absence of Balamuthia DNAin patient
brain tissue (1-µL sample); lane 7, molecular mass marker; lane 8,
Acanthamoeba DNA isolated from patient brain tissue (5-µL sam-
ple); lane 9, absence of Balamuthia DNA isolated from amebae in
patient sample; lane 10, positive control (Acanthamoeba DNA);
lane 11, negative control (water); lane 12, Acanthamoeba DNA
isolated from patient brain tissue (1-µL sample).
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